Skip to main content

NHS: Drugs

Volume 482: debated on Wednesday 5 November 2008

To ask the Secretary of State for Health what representations the Medicines and Healthcare products Regulatory Agency has received from commercial organisations on the effect of publishing the 50 most frequently notified products in its quarterly summary report for importation of unlicensed medicines; and what the reasons were for the publication of the list. (232507)

The Medicines and Healthcare products Regulatory Agency (MHRA) has received two representations from commercial organisations about the publication of the MHRA quarterly summary reports for importation of unlicensed medicines. One expressed commercial concerns and felt that importers may tend to prefer to import listed products at the expense of other products, and the second company commented that the information was relevant, useful and interesting.

The MHRA publishes this list in response to requests from health care professionals for information received during the current review of unlicensed medicines and to provide general information on commonly imported unlicensed products. This may encourage companies to apply for marketing authorisations and also provides transparency on the operation of the importation process.